四环生物
(000518)
| 流通市值：37.78亿 | | | 总市值：37.78亿 |
| 流通股本：10.30亿 | | | 总股本：10.30亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 110,742,539.5 | 81,170,293.95 | 344,383,390.72 | 294,374,160.07 |
| 营业收入 | 110,742,539.5 | 81,170,293.95 | 344,383,390.72 | 294,374,160.07 |
| 二、营业总成本 | 140,621,025.54 | 94,301,571.33 | 377,470,904.68 | 306,462,411.54 |
| 营业成本 | 87,962,676.21 | 65,640,882.89 | 215,921,334.84 | 194,847,175.72 |
| 税金及附加 | 1,071,466.04 | 386,237.77 | 1,548,058.95 | 989,655.59 |
| 销售费用 | 24,199,609.36 | 17,388,417.21 | 63,810,562.69 | 50,791,956.08 |
| 管理费用 | 19,311,954.48 | 8,531,092.55 | 62,011,715.63 | 37,326,928.49 |
| 研发费用 | 7,578,833.68 | 1,927,141.34 | 32,475,696.76 | 21,096,501.38 |
| 财务费用 | 496,485.77 | 427,799.57 | 1,703,535.81 | 1,410,194.28 |
| 其中:利息费用 | 1,003,530.87 | 478,525.07 | 1,687,076.68 | 1,383,517.4 |
| 其中:利息收入 | 552,790.46 | 81,351.55 | 34,434.62 | 10,850.43 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -51,996.85 | -10,252.9 | -31,491.05 | -23,435.2 |
| 加:投资收益 | 0 | 0 | 3,557,542.6 | 1,547,446.6 |
| 资产处置收益 | 0 | 0 | 762,757.42 | 834,647.82 |
| 资产减值损失(新) | 1,890,392.82 | 0 | -3,161,087.42 | 0 |
| 信用减值损失(新) | -170,145.87 | 614,170.57 | -9,782,035.33 | -4,144,005.01 |
| 其他收益 | 24,666.73 | 20,496.73 | 1,216,896.07 | 742,914.83 |
| 四、营业利润 | -28,185,569.21 | -12,506,862.98 | -40,524,931.67 | -13,130,682.43 |
| 加:营业外收入 | 87,299.49 | 0 | 792,078.99 | 300 |
| 减:营业外支出 | 116,114.43 | 0 | 1,191,587.74 | 947,151.91 |
| 五、利润总额 | -28,214,384.15 | -12,506,862.98 | -40,924,440.42 | -14,077,534.34 |
| 减:所得税费用 | 226,321.69 | -224,055.28 | -1,313,609.54 | -581,977.08 |
| 六、净利润 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 | -13,495,557.26 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 | -13,495,557.26 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -25,833,217.42 | -11,313,770 | -37,092,264.36 | -12,697,350.32 |
| 少数股东损益 | -2,607,488.42 | -969,037.7 | -2,518,566.52 | -798,206.94 |
| 扣除非经常损益后的净利润 | -28,174,380.6 | -13,712,822.27 | -41,348,409.7 | -14,731,212.87 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.03 | -0.01 | -0.04 | -0.01 |
| (二)稀释每股收益 | -0.03 | -0.01 | -0.04 | -0.01 |
| 九、综合收益总额 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 | -13,495,557.26 |
| 归属于母公司股东的综合收益总额 | -25,833,217.42 | -11,313,770 | -37,092,264.36 | -12,697,350.32 |
| 归属于少数股东的综合收益总额 | -2,607,488.42 | -969,037.7 | -2,518,566.52 | -798,206.94 |
| 公告日期 | 2026-08-21 | 2026-04-27 | 2026-04-18 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |